Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · IEX Real-Time Price · USD
4.830
-0.070 (-1.43%)
At close: Apr 24, 2024, 3:59 PM
4.700
-0.130 (-2.69%)
After-hours: Apr 24, 2024, 7:31 PM EDT
Company Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma.
The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.
The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
Helius Medical Technologies, Inc.
| Country | United States |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 22 |
| CEO | Dane Carl Andreeff |
Contact Details
Address: 642 Newtown Yardley Road Newtown, Pennsylvania 18940 United States | |
| Phone | 215-944-6100 |
| Website | heliusmedical.com |
Stock Details
| Ticker Symbol | HSDT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001610853 |
| CUSIP Number | 42328V504 |
| ISIN Number | US42328V8019 |
| Employer ID | 36-4787690 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dane Carl Andreeff | President, Chief Executive Officer and Director |
| Jeffrey S. Mathiesen CPA | Chief Financial Officer, Treasurer, Secretary and Director |
| Dr. Antonella Favit-Van Pelt M.D., Ph.D. | Chief Medical Officer |
| Lawrence Picciano | Senior Vice President of Engineering, Quality and Regulatory Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 15, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Apr 5, 2024 | 8-K | Current Report |
| Mar 28, 2024 | 10-K | Annual Report |
| Mar 28, 2024 | 8-K | Current Report |
| Mar 15, 2024 | 8-K | Current Report |
| Mar 4, 2024 | 8-K | Current Report |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | 8-K | Current Report |
| Feb 6, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 5, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |